China Jo-Jo Drugstores, Inc.
CJJD · NASDAQ
9/30/2024 | 3/31/2024 | 9/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| FCF Yield | 0.00% | -83.66% | 9.81% | -6.41% |
| EV / EBITDA | 0.00 | -9.36 | 22.50 | -4.81 |
| Quality | ||||
| ROIC | 0.00% | -6.56% | 0.47% | -33.39% |
| Gross Margin | 0.00% | 19.98% | 20.28% | 22.81% |
| Cash Conversion Ratio | 1.17 | -0.78 | 0.21 | -1.78 |
| Growth | ||||
| Revenue 3-Year CAGR | 39.26% | 27.67% | 15.53% | 12.39% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | -7.59 | 12.84 | -1.19 |
| Interest Coverage | 0.00 | -285.07 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 3.74 | 3.13 | 3.84 |
| Cash Conversion Cycle | 0.00 | -0.17 | 1.88 | 2.02 |